• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于自组织映射的组织蛋白酶k和S抑制剂分类:利用不同结构分子指纹分析不同选择性概况,新型活性化合物发现的设计与应用

Self Organizing Map-Based Classification of Cathepsin k and S Inhibitors with Different Selectivity Profiles Using Different Structural Molecular Fingerprints: Design and Application for Discovery of Novel Hits.

作者信息

Ihmaid Saleh K, Ahmed Hany E A, Zayed Mohamed F, Abadleh Mohammed M

机构信息

Pharmacognosy and Pharmaceutical Chemistry Department, College of Pharmacy, Taibah University, P. O. Box 30039, Al-Madinah Al-Munawarah 41477, Saudi Arabia.

School of Pharmacy and Applied Science, La Trobe University, P. O. Box 199, Bendigo 3552, Australia.

出版信息

Molecules. 2016 Jan 30;21(2):175. doi: 10.3390/molecules21020175.

DOI:10.3390/molecules21020175
PMID:26840291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6272978/
Abstract

The main step in a successful drug discovery pipeline is the identification of small potent compounds that selectively bind to the target of interest with high affinity. However, there is still a shortage of efficient and accurate computational methods with powerful capability to study and hence predict compound selectivity properties. In this work, we propose an affordable machine learning method to perform compound selectivity classification and prediction. For this purpose, we have collected compounds with reported activity and built a selectivity database formed of 153 cathepsin K and S inhibitors that are considered of medicinal interest. This database has three compound sets, two K/S and S/K selective ones and one non-selective KS one. We have subjected this database to the selectivity classification tool 'Emergent Self-Organizing Maps' for exploring its capability to differentiate selective cathepsin inhibitors for one target over the other. The method exhibited good clustering performance for selective ligands with high accuracy (up to 100 %). Among the possibilites, BAPs and MACCS molecular structural fingerprints were used for such a classification. The results exhibited the ability of the method for structure-selectivity relationship interpretation and selectivity markers were identified for the design of further novel inhibitors with high activity and target selectivity.

摘要

成功的药物研发流程中的主要步骤是识别能够以高亲和力选择性结合目标靶点的强效小分子化合物。然而,目前仍缺乏高效且准确的计算方法来研究并预测化合物的选择性特性。在这项工作中,我们提出了一种经济实惠的机器学习方法来进行化合物选择性分类和预测。为此,我们收集了具有已报道活性的化合物,并构建了一个由153种组织蛋白酶K和S抑制剂组成的选择性数据库,这些抑制剂具有药用价值。该数据库有三个化合物集,两个分别对组织蛋白酶K/组织蛋白酶S和组织蛋白酶S/组织蛋白酶K具有选择性的集,以及一个对两者均无选择性的集。我们将该数据库应用于选择性分类工具“涌现自组织映射”,以探索其区分针对一个靶点而非另一个靶点的选择性组织蛋白酶抑制剂的能力。该方法对选择性配体表现出良好的聚类性能,准确率高达100%。在各种可能性中,BAPs和MACCS分子结构指纹被用于此类分类。结果展示了该方法解释结构-选择性关系的能力,并识别出了选择性标记,用于设计具有高活性和靶点选择性的新型抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/6272978/1c87f1047eff/molecules-21-00175-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/6272978/c77d512baef2/molecules-21-00175-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/6272978/16bad7572ca2/molecules-21-00175-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/6272978/cd2f42fb4260/molecules-21-00175-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/6272978/e751a088d587/molecules-21-00175-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/6272978/6f1319350abb/molecules-21-00175-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/6272978/0f4a21276dd9/molecules-21-00175-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/6272978/f5c7be3b4a22/molecules-21-00175-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/6272978/52db35d537df/molecules-21-00175-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/6272978/1c87f1047eff/molecules-21-00175-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/6272978/c77d512baef2/molecules-21-00175-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/6272978/16bad7572ca2/molecules-21-00175-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/6272978/cd2f42fb4260/molecules-21-00175-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/6272978/e751a088d587/molecules-21-00175-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/6272978/6f1319350abb/molecules-21-00175-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/6272978/0f4a21276dd9/molecules-21-00175-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/6272978/f5c7be3b4a22/molecules-21-00175-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/6272978/52db35d537df/molecules-21-00175-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5077/6272978/1c87f1047eff/molecules-21-00175-g009.jpg

相似文献

1
Self Organizing Map-Based Classification of Cathepsin k and S Inhibitors with Different Selectivity Profiles Using Different Structural Molecular Fingerprints: Design and Application for Discovery of Novel Hits.基于自组织映射的组织蛋白酶k和S抑制剂分类:利用不同结构分子指纹分析不同选择性概况,新型活性化合物发现的设计与应用
Molecules. 2016 Jan 30;21(2):175. doi: 10.3390/molecules21020175.
2
Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.半胱氨酸蛋白酶组织蛋白酶K的高效、选择性及口服生物可利用抑制剂的设计
J Med Chem. 2004 Jan 29;47(3):588-99. doi: 10.1021/jm030373l.
3
Improved machine learning models for predicting selective compounds.改进的机器学习模型用于预测选择性化合物。
J Chem Inf Model. 2012 Jan 23;52(1):38-50. doi: 10.1021/ci200346b. Epub 2011 Dec 23.
4
3,4-disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P3 elements for potency and selectivity.3,4-二取代氮杂环丁烷酮作为半胱氨酸蛋白酶组织蛋白酶K的选择性抑制剂。探索用于提高效力和选择性的P3元件。
Bioorg Med Chem Lett. 2005 Mar 1;15(5):1529-34. doi: 10.1016/j.bmcl.2004.12.088.
5
Azepanone-based inhibitors of human cathepsin S: optimization of selectivity via the P2 substituent.基于氮杂环庚酮的人组织蛋白酶 S 抑制剂:通过 P2 取代基优化选择性。
Bioorg Med Chem Lett. 2011 Aug 1;21(15):4409-15. doi: 10.1016/j.bmcl.2011.06.045. Epub 2011 Jun 17.
6
The consequences of lysosomotropism on the design of selective cathepsin K inhibitors.溶酶体亲和性对选择性组织蛋白酶K抑制剂设计的影响。
Chembiochem. 2006 Oct;7(10):1525-35. doi: 10.1002/cbic.200600149.
7
Synthesis of proline analogues as potent and selective cathepsin S inhibitors.脯氨酸类似物的合成作为强效和选择性组织蛋白酶 S 抑制剂。
Bioorg Med Chem Lett. 2013 Jun 1;23(11):3140-4. doi: 10.1016/j.bmcl.2013.04.023. Epub 2013 Apr 16.
8
Design and synthesis of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 1.芳基氨基乙酰胺作为组织蛋白酶S非共价抑制剂的设计与合成。第1部分。
Bioorg Med Chem Lett. 2005 Nov 15;15(22):4979-84. doi: 10.1016/j.bmcl.2005.08.017. Epub 2005 Sep 23.
9
Advances in the discovery of cathepsin K inhibitors on bone resorption.关于骨吸收的组织蛋白酶 K 抑制剂的发现进展。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):890-904. doi: 10.1080/14756366.2018.1465417.
10
Methods for computer-aided chemical biology. Part 5: rationalizing the selectivity of cathepsin inhibitors on the basis of molecular fragments and topological feature distributions.计算机辅助化学生物学方法。第5部分:基于分子片段和拓扑特征分布合理化组织蛋白酶抑制剂的选择性
Chem Biol Drug Des. 2009 Aug;74(2):129-41. doi: 10.1111/j.1747-0285.2009.00848.x. Epub 2009 Jun 22.

引用本文的文献

1
Drug Design and Discovery: Principles and Applications.药物设计与发现:原理与应用
Molecules. 2017 Feb 13;22(2):279. doi: 10.3390/molecules22020279.

本文引用的文献

1
The ChEMBL bioactivity database: an update.《ChEMBL 生物活性数据库更新》
Nucleic Acids Res. 2014 Jan;42(Database issue):D1083-90. doi: 10.1093/nar/gkt1031. Epub 2013 Nov 7.
2
Classification of Aurora kinase inhibitors by self-organizing map (SOM) and support vector machine (SVM).通过自组织映射(SOM)和支持向量机(SVM)对极光激酶抑制剂进行分类。
Eur J Med Chem. 2013 Mar;61:73-83. doi: 10.1016/j.ejmech.2012.06.037. Epub 2012 Jun 26.
3
ChEMBL: a large-scale bioactivity database for drug discovery.ChEMBL:用于药物发现的大型生物活性数据库。
Nucleic Acids Res. 2012 Jan;40(Database issue):D1100-7. doi: 10.1093/nar/gkr777. Epub 2011 Sep 23.
4
Difluoroethylamines as an amide isostere in inhibitors of cathepsin K.二氟乙基胺作为一种酰胺等排体在组织蛋白酶 K 抑制剂中的应用。
Bioorg Med Chem Lett. 2011 Feb 1;21(3):920-3. doi: 10.1016/j.bmcl.2010.12.070. Epub 2010 Dec 19.
5
Discriminating of HMG-CoA reductase inhibitors and decoys using self-organizing maps.使用自组织映射区分 HMG-CoA 还原酶抑制剂和诱饵。
Mol Divers. 2011 Aug;15(3):655-63. doi: 10.1007/s11030-010-9288-8. Epub 2010 Nov 12.
6
6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors.6-苯-1H-咪唑并[4,5-c]吡啶-4-甲腈作为组织蛋白酶 S 抑制剂。
Bioorg Med Chem Lett. 2010 Aug 1;20(15):4350-4. doi: 10.1016/j.bmcl.2010.06.072. Epub 2010 Jun 17.
7
Design and evaluation of bonded atom pair descriptors.键合原子对描述符的设计与评估。
J Chem Inf Model. 2010 Apr 26;50(4):487-99. doi: 10.1021/ci900512g.
8
Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.鉴定和优化克氏锥虫半胱氨酸蛋白酶抑制剂:克氏锥虫 cruzain、rhodesain 和 TbCatB。
J Med Chem. 2010 Jan 14;53(1):52-60. doi: 10.1021/jm901069a.
9
Dipeptidyl nitrile inhibitors of Cathepsin L.组织蛋白酶L的二肽基腈抑制剂
Bioorg Med Chem Lett. 2009 Aug 1;19(15):4280-3. doi: 10.1016/j.bmcl.2009.05.071. Epub 2009 May 27.
10
SVM model for virtual screening of Lck inhibitors.用于Lck抑制剂虚拟筛选的支持向量机模型
J Chem Inf Model. 2009 Apr;49(4):877-85. doi: 10.1021/ci800387z.